SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043439
Filing Date
2021-08-11
Accepted
2021-08-11 16:16:34
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itos-10q_20210630.htm   iXBRL 10-Q 2803500
2 EX-10.1 itos-ex101_116.htm EX-10.1 1384942
3 EX-31.1 itos-ex311_8.htm EX-31.1 18393
4 EX-31.2 itos-ex312_7.htm EX-31.2 22690
5 EX-32.1 itos-ex321_9.htm EX-32.1 12239
  Complete submission text file 0001564590-21-043439.txt   9672804

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA itos-20210630.xsd EX-101.SCH 58051
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itos-20210630_cal.xml EX-101.CAL 45301
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itos-20210630_def.xml EX-101.DEF 195634
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itos-20210630_lab.xml EX-101.LAB 399859
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itos-20210630_pre.xml EX-101.PRE 315123
11 EXTRACTED XBRL INSTANCE DOCUMENT itos-10q_20210630_htm.xml XML 1245834
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39401 | Film No.: 211163622
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences